From October 1, 2023 to December 31, 2023, the company has repurchased 928,485 shares, representing 1.17% for $36.65 million. With this, the company has completed the repurchase of 3,225,224 shares, representing 4% for $125 million under the buyback announced on July 27, 2023.
Integra LifeSciences Holdings Corporation
Equities
IART
US4579852082
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
28.34 USD | -0.25% | -1.19% | -34.93% |
Apr. 04 | North American Morning Briefing : Focus Turns to -2- | DJ |
Apr. 03 | Citigroup Upgrades Integra LifeSciences to Neutral From Sell With $38 Price Target | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-34.93% | 2.23B | |
-2.31% | 187B | |
-3.20% | 106B | |
-5.04% | 66.9B | |
+0.20% | 49.45B | |
+17.29% | 48B | |
+4.06% | 40.84B | |
+2.36% | 26.25B | |
+2.07% | 26.48B | |
+12.96% | 24.62B |
- Stock Market
- Equities
- IART Stock
- News Integra LifeSciences Holdings Corporation
- Tranche Update on Integra LifeSciences Holdings Corporation's Equity Buyback Plan announced on July 27, 2023.